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UVBwavelengths of light induce the formation of photoprod-
ucts in DNA that are potentially mutagenic if not properly
removed by the nucleotide excision repair machinery. As an
additional mechanism to minimize the risk of mutagenesis,
UVB-irradiated cells also activate a checkpoint signaling cas-
cade mediated by the ATM and Rad3-related (ATR) and check-
point kinase 1 (CHK1) kinases to transiently suppress DNA syn-
thesis and cell cycle progression. Given that keratinocytes in
geriatric skin display reduced activation of the insulin-like
growth factor 1 receptor (IGF-1R) and alterations inDNArepair
rate, apoptosis, and senescence following UVB exposure, here
weused cultured humankeratinocytes in vitro and skin explants
ex vivo to examine how IGF-1R activation status affects ATR-
CHK1 kinase signaling and the inhibition of DNA replication
following UVB irradiation. We find that disruption of IGF-1R
signaling with small-molecule inhibitors or IGF-1 withdrawal
partially abrogates both the phosphorylation and activation of
CHK1 by ATR and the accompanying inhibition of chromo-
somal DNA synthesis in UVB-irradiated keratinocytes. A criti-
cal protein factor that mediates both ATR-CHK1 signaling and
nucleotide excision repair is replication protein A, and we find
that its accumulation on UVB-damaged chromatin is partially
attenuated in cells with an inactive IGF-1R. These results indi-
cate that mutagenesis and skin carcinogenesis in IGF-1-defi-
cient geriatric skinmay be caused by defects inmultiple cellular
responses to UVB-induced DNA damage, including through a
failure to properly suppress DNA synthesis on UVB-damaged
DNA templates.
Themajor risk factor for the development of non-melanoma
skin cancer (NMSC)2 is the exposure to UV wavelengths of
sunlight, which generate photoproducts in genomic DNA that
give rise tomutations whenDNApolymerases incorrectly copy
the damaged bases. Nucleotide excision repair is the solemech-
anism for removing these photoproducts from genomic DNA
in human cells (1, 2), and mutations in excision repair genes
give rise to the skin cancer-prone disease xeroderma pigmen-
tosum and to the premature aging disease Cockayne syndrome
(3, 4).
In addition to DNA repair, UV-irradiated cells possess DNA
damage checkpoint signaling cascades that inhibit DNA syn-
thesis ondamaged templates to limit the likelihoodofmutagen-
esis. This suppression of DNA synthesis occurs through a num-
ber of mechanisms, including by transiently preventing cells
from entering the S phase of the cell cycle, inhibiting the initi-
ation of DNA replication at new origins, and slowing the rate of
ongoing replication fork progression (5–7). In addition to
directly preventing the miscopying of damaged DNA bases,
these checkpoint responses also allow additional time for DNA
repair to take place prior to the resumption of DNA synthesis.
Critical components of this UV-induced DNA damage sig-
naling response are the protein kinases ATM and Rad3-related
(ATR) and checkpoint kinase 1 (CHK1) (8–11). CHK1 is
directly phosphorylated and activated by ATR (12), and,
together, these proteins phosphorylate numerous additional
proteins associated with DNA replication and cell cycle pro-
gression (13, 14). In UV-irradiated cells, the signal that triggers
the activation the ATR-CHK1 pathway is thought to be regions
of single-stranded DNA (ssDNA) produced by replicative
helicase-polymerase uncoupling (15) and by gaps generated
during nucleotide excision repair (16–18). This ssDNA is
thought to then become bound by replication protein A (RPA),
which coordinates many aspects of ATR-CHK1 signaling (19–
21), including the recruitment of the ATR kinase (22), its acti-
vator module comprised of the 9-1-1 clamp and TopBP1 (23–
26), and the adaptor proteins Timeless, Tipin, and Claspin,
which specifically facilitate the phosphorylation of CHK1 (27).
The importance of the ATR-CHK1 pathway in DNA damage
responses and carcinogenesis is highlighted by mouse genetic
studies in which loss of one allele of either ATR or CHK1 has
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been shown to promote tumorigenesis (28–31), including in
the skin (32).
There are an abundance of genetic and environmental fac-
tors that may influence DNA repair, mutagenesis, and carcino-
genesis associated with exposure to UV radiation (UVR). How-
ever, the observation that more than 80% of NMSCs are found
in patients over the age of 60 (33, 34) has indicated that age and
the physiology of aged skinmay contribute to the propensity for
skin carcinogenesis.
Consistent with this hypothesis, the age-dependent accumu-
lation of senescent fibroblasts in the dermis of the skinmay lead
to a tumor-promoting environment that influences how kera-
tinocytes in the epidermis respond to environmental carcino-
gens such asUVR. Indeed, previous studies have shown that the
production of insulin-like growth factor 1 (IGF-1), which is pri-
marily supplied to epidermal keratinocytes by dermal fibro-
blasts (35, 36), is decreased in both senescent fibroblasts in vitro
and geriatric skin in vivo (37). The observation that epidermal
keratinocytes in geriatric skin display reduced activation of the
IGF-1 receptor (IGF-1R) further supports the notion that the
IGF-1/IGF-1R axis becomes disrupted as people age (37, 38).
Interestingly, previous in vitro and in vivo studies with cul-
tured keratinocytes and human skin have shown that the IGF-
1/IGF-1R axis influences both the UVB photoproduct removal
rate (39, 40) and various cellular outcomes following UVB
exposure, including apoptosis and senescence (37, 40–42).
Because the ATR-CHK1 pathway is an additional and impor-
tant regulator of the cellular response to UVR-associated DNA
damage, we have now examined how the status of the IGF-1R
influences the activity of the ATR-CHK1 signaling pathway.
Using cultured human keratinocytes in vitro and skin
explants ex vivo, we find that maximal activation of the ATR-
CHK1 kinase network and suppression of DNA synthesis after
UVB irradiation requires an intact IGF-1/IGF-1R system.
Importantly, we observed that RPA, which plays critical roles in
both ATR-CHK1 signaling (19, 20) and in UV photoproduct
removal by nucleotide excision repair (43, 44), fails to properly
accumulate on UVB-damaged chromatin in cells exposed to an
IGF-1R inhibitor. Together, these results suggest that defects in
both nucleotide excision repair and ATR-CHK1 checkpoint
signaling may contribute to aging-associated mutagenesis and
carcinogenesis in human skin.
Results
IGF-1R Inhibition Partially Abrogates ATR-CHK1 Signaling
and the Suppression of DNA Synthesis in UVB-irradiated,
Telomerase-immortalized Human Keratinocytes in Vitro—
Given the well described roles of the ATR and CHK1 kinases in
suppressing DNA synthesis in UV-irradiated cells (8, 9, 11) and
the recognition that the activation status of the IGF-1R affects
the fate of UVB-irradiated keratinocytes in vitro and in vivo (37,
39, 41, 42), we treated N-TERT keratinocytes with an IGF-1R
inhibitor for 1 h prior to exposure to UVB radiation and then
monitored the kinetics of CHK1 phosphorylation. As shown in
Fig. 1A (lanes 1–6), exposure of cells to 500 J/m2 of UVB
induced a robust and transient phosphorylation of CHK1 on
the ATR target residue Ser-345 that peaked 0.5 h following
irradiation.AlthoughUVB-irradiated cells thatwere pretreated
with the IGF-1R inhibitor AG538 were still capable of inducing
CHK1 phosphorylation with similar general kinetics as control
cells, the extent of phosphorylation was reduced by 3- to
4-fold (Fig. 1A, lanes 7–12). Importantly, this defect in ATR
kinase signalingwas not specific to its target CHK1, however, as
we also observed that phosphorylation of the ATR substrate
KAP-1 was also partially abrogated by inhibition of the IGF-1R.
To examine these findings further with UVB doses that do
not induce significant amounts of apoptosis in these cells (37),
we repeated the experiment using a range of lower UVB expo-
sures. As shown in Fig. 1B, regardless of the UV light dose, the
level of CHK1 and KAP-1 phosphorylation was reduced by up
to 3-fold on average when cells were treated with the IGF-1R
inhibitor AG538. We conclude that the UVB-induced activa-
tion of ATR and CHK1 is disrupted when the IGF-1R is inhib-
ited in human keratinocytes.
Through the targeting of proteins that promote S phase
entry, replication origin activation, and replication fork pro-
gression and stability, the ATR-CHK1 pathway actively and
transiently suppresses DNA synthesis in cells exposed to UVR
and other DNA-damaging agents (8, 9, 11). Thus, to determine
whether the abrogation of ATR-CHK1 signaling observed in
cells treated with an IGF-1R inhibitor was associated with an
altered rate of DNA synthesis, we measured DNA replication
using a BrdU immuno-dot blot assay (47). As shown in Fig. 1C,
DNA synthesiswas inhibited in aUVBdose-dependentmanner
in bothDMSO- andAG538-treated cells. However, in the pres-
ence of an IGF-1R inhibitor, DNA synthesis failed to be sup-
pressed to the extent observed in control cells.
At low fluences of UV irradiation, the inhibition of DNA
synthesis is only transient, and cells are able to recover and
resume DNA replication. Consistent with this classical re-
sponse, maximal inhibition of DNA replication occurred 1–2 h
after UVB exposure, and the DNA synthesis rate ultimately
returned to near normal levels by 6.5 h post-UVB irradiation
(Fig. 1D). In cells treated with the IGF-1R inhibitor, however,
DNA synthesis was only partially suppressed. Thus, consistent
with the analysis of ATR-CHK1 signaling, DNA synthesis failed
to be properly stopped following UVB exposure in cells with an
inactive IGF-1R.
IGF-1R Status Impacts ATR-CHK1 Signaling and DNA Rep-
lication Inhibition in Primary Keratinocytes—To confirm the
results presented in Fig. 1 with non-transformed cells, we
obtained primary keratinocytes fromhuman foreskins and then
repeated our measurements of ATR-CHK1 signaling and DNA
synthesis using two different inhibitors of the IGF-1R. As
shown in Fig. 2A, treatment of primary keratinocytes with the
IGF-1R competitive inhibitor AG538 or non-competitive
inhibitor PPP reduced UVB-induced CHK1 phosphorylation
by 50% in comparison with DMSO-treated cells. Similarly,
when we examined the UVB-induced inhibition of DNA syn-
thesis with a BrdU immuno-dot blot assay, we observed that
keratinocytes treated with the IGF-1R inhibitors failed to
inhibit DNA synthesis to the extent found in control, DMSO-
treated cells. Together, these results suggest that IGF-1R inhi-
bition interferes with ATR-CHK1 kinase signaling and DNA
replication suppression in both primary and telomerase-im-
mortalized UVB-irradiated human keratinocytes.
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IGF-1 Is Required for Optimal ATR-CHK1 Signaling—We
next examined how the presence or absence of IGF-1 in the
culture medium affected the response of keratinocytes to UVB.
We therefore starved N-TERTs of IGF-1 for 18–24 h and then
supplemented the culture medium with recombinant IGF-1 or
PBS vehicle for 1 h prior to exposure to UVB. As shown in Fig.
3A, a more robust phosphorylation of CHK1 was observed in
cells that had been exposed to IGF-1 than in cells starved of
IGF-1.
We next examined how the presence or absence of IGF-1
affected the inhibition of DNA synthesis following UVB irradi-
ation. We observed that the inhibition of DNA replication in
UVB-irradiated keratinocytes was dependent on the concen-
tration of IGF-1 in the culture medium (Fig. 3B). Experiments
monitoring the kinetics of DNA synthesis following UVB irra-
diation showed that the inhibition of DNA synthesis at early
time points followingUVBexposurewas significantly greater in
cells exposed to IGF-1 than cells starved of IGF-1 (Fig. 3C).
Thus, these results demonstrate that both IGF-1 withdrawal
and IGF-1R inhibition have qualitatively similar effects on
ATR-CHK1 signaling andDNA synthesis following UVB expo-
sure. The quantitative differences observed between these two
experimental approaches likely arise from the effects of pro-
longedwithdrawal of an essential keratinocyte growth factor on
cell cycle distribution, which, among other effects, may impact
the relative the contribution of helicase-polymerase uncou-
FIGURE 1. Inhibition of the IGF-1/IGF-1R pathway in N-TERT keratinocytes partially abrogates ATR-CHK1 signaling and the suppression of DNA
synthesis following UVB irradiation in vitro. A, TERT-immortalized human keratinocytes were treated for 1 h with DMSO or the IGF-1 receptor inhibitor
AG538 (10 M) prior to exposure to 500 J/m2 of UVB radiation. Cells were harvested at the indicated time points, and cell lysates were examined by immuno-
blotting. The quantitation shows the results from three independent experiments in which phospho-CHK1 (CHK1-P, Ser-345) signals were normalized to total
CHK1. The highest CHK1-P/CHK1 ratio for each blot was set to an arbitrary value of 100. All other signals were normalized to this value, and themean S.E. are
shown. The asterisks indicate that CHK1-P phosphorylation in the DMSO- and AG538-treated cells are significantly different (*, p 0.05). B, cells were treated
as in A, except that cells were exposed to different fluences of UVB light and then harvested 1 h post-irradiation. The quantitation shows results from four
independent experiments. Theasterisks indicate a significantdifference inCHK-1phosphorylationat the indicated timepoints (*,p0.05).C, cellswere treated
as inB, except that BrdU (10M)was added to the culturemedium immediately after irradiationwith the indicateddosesofUVB light. Cellswereharvested0.5h
later. Genomic DNA was purified, dot-blotted onto a nitrocellulose membrane, and probed with an anti-BrdU antibody. Blots were reprobed with an anti-
ssDNA antibody to ensure equal loading. The quantitation shows results (mean S.E.) for each UVB dose from two to five independent experiments in which
BrdU signals for UVB-irradiated cells were normalized to a non-irradiated control. The asterisks indicate that DNA synthesis in the AG538-treated cells is
significantly different from in theDMSO-treated cells (p 0.05).D, Cells exposed to 60 J/m2 of UVB radiationwere analyzed as inC, except that BrdUwas added
0.5 h prior to cell harvesting at the indicated time points. The quantitation shows the results from three to five independent experiments for each time point.
The asterisks indicate a significant difference in DNA synthesis at the indicated time points (*, p 0.05).
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pling and nucleotide excision repair gaps to ATR-CHK1 acti-
vation. Furthermore, we noted that withdrawal of IGF-1 for
18–24 h led to a modestly reduced rate of basal DNA synthesis
in non-irradiated cells (data not shown).
IGF-1R Inhibition Abrogates ATR-CHK1 Signaling in Human
Skin Explants ex Vivo—To extend our in vitro findings with
keratinocytes to the more physiological environment of whole
skin, we used deidentified skin tissue derived from human skin
contour surgeries (abdominoplasties). As shown in Fig. 4A,
exposure of human skin to UVB light led to a dose-dependent
increase in the phosphorylation of CHK1 on both an ATR tar-
get site (Ser-345) and an autophosphorylation site (Ser-296)
within the epidermis of the skin. Examination of the kinetics of
CHK1 phosphorylation showed that CHK1 phosphorylation
peaked 0.5–1 h after UV irradiation (Fig. 4B), similar to that
observed in keratinocytes in vitro. Importantly, these results
provide the first experimental evidence that the ATR-CHK1
pathway can be activated in the epidermis of human skin
exposed to UVB.
Wenext examined how inhibition of the IGF-1R affected this
response to UVB radiation. We therefore topically applied
either DMSO or the IGF-1R inhibitor AG538 to skin samples
0.5 h prior to exposure to UVB light and then harvested the
epidermis 0.5–1 h after irradiation. As shown in Fig. 4C, UVB
irradiation-induced CHK1 and KAP-1 phosphorylation was
partially abrogated in the presence of the IGF-1R inhibitor.
Quantitation of several independent experiments with differ-
ent skin samples demonstrated that CHK1 phosphorylation
was reduced by more than 60% at high doses of UVB light.
These results show that, similar to human keratinocytes in
vitro, the status of the IGF-1R affects the activation of the ATR-
CHK1 pathway in keratinocytes within the context of the
human epidermis ex vivo.
IGF-1R Inhibition Interferes with Proper RPA Loading onto
UVB-damagedChromatin—To characterize themechanismby
which theATR-CHK1 pathway is disrupted by the inhibition of
the IGF-1R, we next considered how the status of the IGF-1R
affects the accumulation of RPA on UVB-damaged chromatin.
RPA plays multiple roles in ATR-CHK1 signaling by directly
interacting with several components of the signaling reaction,
including the ATRIP subunit of the ATR kinase holoenzyme
(19, 22), the ATR kinase-activating 9-1-1 clamp and TopBP1
module (23, 24), andTipin, which, through binding to the adap-
tor protein Claspin, is thought to facilitate the recruitment of
CHK1 to ATR (27).
As expected, we observed that RPA rapidly accumulated on
the chromatin fraction of UVB-irradiated N-TERT cells and
peaked1 h after UVB exposure (Fig. 5A, lanes 1–5). However,
in cells treated with the IGF-1R inhibitor AG538, we noted two
relevant observations. First, the level of chromatin-bound RPA
was elevated nearly 2-fold even prior to UVB exposure. Second,
the chromatin level of RPA then failed to undergo a significant
increase followingUVBexposure. These results indicate that an
intact IGF-1R signaling network is required for RPA to properly
function in promoting the ATR-CHK1 pathway following UVB
irradiation.
Discussion
The efficient removal of UVB photoproducts from genomic
DNA by the nucleotide excision repair machinery is critical to
the fate of UVB-irradiated cells; incomplete repair is associated
with a number of potential outcomes, including mutagenesis,
senescence, and apoptosis. Although the nucleotide excision
repair system is the sole mechanism for removing the photo-
products from DNA (1, 2), additional DNA damage response
signaling proteins, including the ATR and CHK1 protein
kinases, also influence cellular responses to UVR (5–9).
The classical functions of theATRandCHK1kinases include
the induction of a transient suppression of DNA synthesis
and the activation of cell cycle checkpoints (8–10). However,
ATR has also been reported to facilitate UV photoproduct
removal through direct (48–51) and indirect means (52, 53).
ATRmay also induce cellular senescence (54, 55) and promote
or prevent apoptosis (47), depending on the specific stimulus.
Given that the activation status of the IGF-1R also influences
these outcomes in UVB-irradiated human keratinocytes
(37–39, 41, 42) and is known to be deficient in geriatric skin
(37), determining how IGF-1/IGF-1R signaling influences
ATR-CHK1 pathway function in UVB-irradiated keratino-
cytes may uncover novel insights into the mechanism of
aging-associated skin carcinogenesis.
Using IGF-1 ligand withdrawal and small-molecule inhibi-
tors of the IGF-1R, we showed here that inactivation of the
IGF-1R is associated with a partial disruption of ATR-CHK1
signaling and DNA synthesis inhibition in UVB-irradiated
keratinocytes. The single-stranded DNA-binding protein RPA
interacts with several components of the ATR-CHK1 signal
transduction network, and thus its failure to accumulate on
chromatin following UVB exposure provides a logical mecha-
nistic explanation for the observed defects in DNA damage sig-
naling. Moreover, RPA is also one of the six essential compo-
FIGURE 2.Optimal activationofATR-CHK1 signaling and replication inhi-
bition in UVB-irradiated primary normal human keratinocytes requires
the IGF-1/IGF-1R system. A, primary human foreskin keratinocytes were
treated for 1 h with DMSO or the IGF-1 receptor inhibitors AG538 or PPP
before exposure to 60 J/m2 of UVB radiation. Cells were harvested 0.5 h later
and analyzed by immunoblotting. The graph shows the results (mean S.E.)
from three independent experiments with three different foreskin keratino-
cyte samples. B, primary keratinocytes treated with DMSO, AG538, or PPP
were exposed to 60 J/m2 and then incubated with BrdU for 0.5 h. Genomic
DNA was analyzed by immuno-dot-blotting as in Fig. 1. Results show the
mean S.E. from three independent experiments. The asterisks indicate that
CHK1 phosphorylation or DNA synthesis in the AG538-treated cells is signifi-
cantly different from in the DMSO-treated cells (*, p 0.05).
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nents of the nucleotide excision repair system, in which it
facilitates damage recognition and coordinates various enzy-
matic activities (43, 44). Thus, defective recruitment of RPA to
UVB-damaged chromatinmay also contribute to the previously
reported inhibition of UVB photoproduct removal in keratino-
cytes with an inactive IGF-1R (39, 40).
The mechanism by which RPA is deregulated in cells with
an inactive IGF-1R remains to be determined. However, we
note that an insufficient supply of RPA has been recognized
as a contributor to a variety of negative cellular phenotypes
in response to replication-associated genotoxic stress (53,
56–60). Thus, the generation of endogenous replicative
FIGURE 3. IGF-1 is required for UVB-induced ATR-CHK1 signaling and inhibition of DNA synthesis in human keratinocytes. A, N-TERT keratinocytes
starved of IGF-1 for 18–24 h were treated with PBS or 20 ng/ml recombinant IGF-1 for 1 h before exposure to 60 J/m2 of UVB. Cell lysates were analyzed by
immunoblotting. The quantification shows results (mean S.E.) from three independent experiments. B, N-TERTs starved of IGF-1 as in Awere exposed to the
indicated concentrations of recombinant IGF-1 for 1 h. Cells were then exposed to 60 J/m2 of UVB radiation, incubated with BrdU, and harvested 0.5 h later.
GenomicDNAwas isolated and analyzedby immuno-dot-blotting. Thegraph shows themean ( S.E.) amount ofDNA synthesis relative to non-irradiated cells
from four to ten independent experiments. C, cells deprived of IGF-1 or exposed for 1 h to 20 ng/ml of recombinant IGF-1 were exposed to UVB light and then
incubated for 0.5 h with BrdU immediately prior to harvesting at the indicated time points. Genomic DNA was analyzed by immuno-dot-blotting. The results
indicate the relative level of DNA synthesis at each time point from three separate experiments. The asterisks indicate that CHK1 phosphorylation or DNA
synthesis in the AG538-treated cells is significantly different from in the DMSO-treated cells (*, p 0.05).
FIGURE 4. Inhibition of IGF-1R in human skin explants ex vivo partially blocks UVB-induced ATR-CHK1 signaling. A, human skin epidermis from routine
abdominoplasty surgerieswas separated from thedermis by vacuum for 60–90minprior to exposure to the indicated fluences ofUVB light. The epidermiswas
isolated and then analyzed by immunoblotting. B, human epidermis was processed as in A, exposed to 1000 J/m2 of UVB radiation, and harvested at the
indicated time points for immunoblotting analysis. C, solutions of DMSO or AG538 were applied to human abdominoplasty skin for 0.5 h prior to exposure to
the indicated dose of UVB radiation. The epidermis was harvested 0.5–1 h later and analyzed by immunoblotting. D, the mean ( S.E.) level of CHK1
phosphorylation from two to four independent experiments at each UVB dose. The asterisks indicate that CHK1 phosphorylation in the AG538-treated
epidermis is significantly different from in the DMSO-treated epidermis (*, p 0.05).
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stress by aberrant IGF-1 signaling could, in principle, limit
the amount of RPA available for various UV DNA damage
responses, including nucleotide excision repair and ATR-
CHK1 signaling.
Nonetheless, the results presented here demonstrate that
IGF-1R status impacts a second DNA damage response (the
suppression of DNA synthesis) following UVB exposure. A
schematic summarizing these findings is provided in Fig. 6A.
Together, nucleotide excision repair and ATR-CHK1-medi-
ated inhibition of DNA replication likely cooperate to prevent
mutagenesis and promote cell survival in cells with an activate
IGF-1R. Under conditions of more extensive DNA damage,
ATRmay also facilitate a protective senescence (54, 55) in cells
with an intact IGF-1/IGF-1R system (42) that contributes to the
prevention of carcinogenesis. However, when IGF-1 levels are
deficient, the decreased rate of photoproduct removal by nucle-
otide excision repair coupledwith an abrogation ofATR-CHK1
signaling and replication inhibition may increase the risk of
mutagenesis, decrease the likelihood of senescence, and, ulti-
mately, promote skin carcinogenesis (Fig. 6B).
The fact that IGF-1 expression is low in the skin of geriatric
patients (37) has important implications for understanding the
mechanisms and origins of non-melanoma skin cancers in geri-
atric patients. Defects in both DNA repair and DNA damage
signaling because of low IGF-1 may therefore contribute to the
risk of developing skin cancer. Interestingly, dermal rejuvena-
tion approaches have been shown to increase IGF-1 levels in the
skin and to reduce the number of proliferating, basal keratino-
cytes with unrepaired DNA photoproducts (61–63). Thus,
understanding the molecular mechanisms of DNA repair and
DNAdamage signaling in the context of the IGF-1 pathway and
aging may offer new approaches for preventing NMSCs in sus-
ceptible individuals.
Experimental Procedures
Cell Culture—Primary keratinocytes from human neonatal
foreskins and telomerase-immortalized keratinocytes (N-TERTs)
(45) were cultured in EpiLife medium supplemented with
human keratinocyte growth supplement (Thermo Fisher Sci-
entific) and penicillin/streptomycin (Gibco). Experiments with
cells deprived of IGF-1 were grown for 18–24 h in the same
medium but with IGF-1 omitted from the human keratinocyte
growth supplement. Recombinant IGF-1 was added to the cul-
ture medium at the indicated final concentration 1 h prior to
UVB exposure. The IGF-1R inhibitors I-OMe-Tryphostin
AG538 (Sigma) and picropodophyllin (PPP, Selleck Chem)
were dissolved in DMSO and added to medium at 10 M or 5
M, respectively, 1 h prior to UVB irradiation. Cells were
exposed to the indicated fluences ofUVB radiation as described
previously (37) using a Philips F20T12 UV bulb at a dose rate of
5 J/m2/s.
Human Skin Epidermis—The epidermis of human skin from
abdominoplasty procedures was separated from the underlying
dermis by inducing suction blisters for 60–90 min with 20-ml
syringes placed on the skin and attached via tubing to vacuum
pumps. The IGF-1R inhibitor AG538 (20 M in DMSO) or
DMSO (vehicle) was then dispensed topically onto the skin,
which, after a 30-min incubation, was subsequently exposed to
the indicated fluences of UVB radiation. Following the various
treatments, the epidermis was removed from the skin using
forceps, washed twicewith cold PBS, and then stored at80 °C.
FIGURE 5. RPA accumulation on chromatin after UVB irradiation is partially abrogated by inhibition of the IGF-1/IGF-1R signaling. A, N-TERTs treated
with DMSO or AG538 were exposed to 125 J/m2 of UVB radiation. At the indicated time points, cells were harvested for fractionation and enrichment of
chromatin-associated proteins, which were analyzed by immunoblotting with antibodies against the 70-kDa subunit of RPA (RPA70) or histone H3. The blot
was also stained with Ponceau S prior to immunoblotting to detect total histones and ensure equal loading. B, quantitation of chromatin-bound RPA.
Experiments performed as in Awere quantified so that themaximal RPA70 signal on each experimental blot was set to an arbitrary value of 100, and all other
samples were normalized to this value. Data show the mean  S.E. from four independent experiments. The asterisks indicate the time points at which
chromatin-bound RPA was significantly reduced in the AG538-treated cells relative to the DMSO-treated cells (*, p 0.05).
FIGURE6.Modeldescribinghowdeficient IGF-1/IGF-1Rsignaling impacts
the cellular response toUVB-inducedDNAdamage.A, exposure of cells to
UVB wavelengths of light results in the formation of UV photoproducts in
DNA. In the presence of sufficient levels of IGF-1, this DNA damage can be
repaired by nucleotide excision repair but also activates ATR-CHK1 signaling
to suppress DNA synthesis. Together, DNA repair and DNA synthesis inhibi-
tion are expected to limit mutagenesis and, subsequently, carcinogenesis.
Under conditions of more extensive DNA damage, cells may also undergo a
protective senescence to prevent carcinogenesis. B, when IGF-1 levels are
deficient and IGF-1R signaling is suboptimal, the nucleotide excision repair
rate is reduced, and DNA synthesis fails to be properly suppressed. Defects in
these processesmay therefore increase the risk ofmutagenesis, decrease the
likelihood of cells undergoing senescence, and, subsequently, promote
carcinogenesis.
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Epidermal lysates were prepared by sonicating the epidermis in
radioimmune precipitation buffer and then processed for
immunoblotting as described below.
Cell Lysis and Analysis of Chromatin-associated Proteins—
Media from treated/irradiated cells was discarded, and the cells
were then washed once with cold PBS before scraping the cells
from the plate in cold PBS. The cells were pelleted by gentle
centrifugation and either frozen and stored at 80 °C or
directly lysed for 20 min on ice in radioimmune precipitation
buffer (50 mM Tris-HCl (pH 7.5), 150 mMNaCl, 2 mM EDTA, 2
mM EGTA, 1% Triton X-100, 1% sodium deoxycholate, and
0.1% SDS; Teknova) containing a protease inhibitor mixture
(Sigma), 1 mMDTT, 0.1 mM PMSF, 10 mMNaF, 1 mMNa2VO3,
and 10mMglycerophosphate. Sampleswere briefly subjected to
five to six pulses with an F60 Sonic Dismembrator (Fisher Sci-
entific) before centrifugation in amicrocentrifuge for 15min at
maximum speed. The soluble cell lysates were then transferred
to new tubes. For the analysis of chromatin-associated proteins,
cells were extracted three to four times with buffer A (10 mM
HEPES-KOH (pH 7.6), 10 mM KCl, 1.5 mM MgCl2, 0.34 M
sucrose, 10% glycerol, and 0.1% Triton X-100 containing 1 mM
DTT and protease and phosphatase inhibitors) to fully sepa-
rate soluble proteins from chromatin-associated proteins, as
described previously (46). TheTriton-resistant chromatin frac-
tion was subsequently resuspended in buffer A, supplemented
with 1 SDS-PAGE sample buffer (50 mM Tris-HCl (pH 6.8),
5% glycerol, 100 mM DTT, 1% SDS, and 0.005% bromphenol
blue), and sonicated to shear the genomic DNA.
Immunoblotting—Equivalent amounts of soluble or insolu-
ble cell lysates were separated by SDS-PAGE, transferred to
nitrocellulose, and then probed by immunoblotting using
standard procedures. Primary antibodies included antibodies
against CHK1 (sc-8408) and actin (I-19) from Santa Cruz Bio-
technology; RPA70 (A300-421A) and phospho-KAP-1 (Ser-
824; A300-767A) from Bethyl Laboratories; and phospho-
CHK1 (Ser-345; 2348), phospho-CHK1 (Ser-296; 2349), and
histone H3 (3638) fromCell Signaling Technology. All primary
antibodies were used at a 1:1000 or 1:2000 dilution in 1TBST
(50 mM Tris-HCl (pH 7.4), 135 mM NaCl, and 0.1% Tween 20).
Secondary antibodies included horseradish peroxidase-linked
anti-rabbit IgG and anti-mouse IgG from GE Amersham Bio-
sciences, Pierce, or Invitrogen and anti-goat IgG (sc-2020) from
Sigma. Chemiluminescence was visualized with Clarity West-
ern ECL substrate (Bio-Rad) or SuperSignal West Femto sub-
strate (Thermo Scientific) using a Molecular Imager Chemi-
DocXRS system (Bio-Rad). Chemiluminescent signalswithin
the linear range of detectionwere quantified using ImageQuant
software (GE Healthcare). For each soluble lysate immunoblot,
the phospho-CHK1 signal was quantified and normalized to
total CHK1 levels in the same protein lysate, and themaximum
signal for each blot was set to an arbitrary value of 100. All other
phospho-CHK1/CHK1 ratios were then normalized to this
value for each immunoblot. All experiments analyzing ATR-
CHK1 signaling were repeated three to four times, and the
mean  S.E. of the phospho-CHK1protein/CHK1 was deter-
mined and plotted. Statistically significant differences were
determined using a Student’s t test.
Immuno-Dot Blot Analysis—DNA synthesis was measured
with an immuno-dot blot assay (47). BrdUwas added to the cell
culture medium at a final concentration of 10 g/ml 30 min
prior to cell harvesting at the indicated time points following
UVB irradiation. Cells were then washed in cold PBS, scraped
from the plate, centrifuged at 1600 g in a microcentrifuge for
5 min at 4 °C, and then stored at80 °C until ready for further
processing. Genomic DNA was next purified with either a
QIAamp DNA Mini Kit (Qiagen) or a GenElute Mammalian
Genomic DNA Miniprep kit (Sigma) and quantified using a
Nanodrop spectrophotometer and/or agarose gel electropho-
resis. Genomic DNA (100–200 ng) diluted in water was heated
at 90 °C for 10 min before neutralization with an equal volume
of 2 M ammonium acetate and incubation on ice for 10 min.
DNA was immobilized on a nitrocellulose membrane with a
Hybri-Dot manifold (Bethesda Research Laboratories) and
baked at 80 °C for 90 min. Blots were blocked in 5% milk in
TBST and probed overnight with an anti-BrdU antibody
(Sigma, B2531). Blots were reprobedwith anti-ssDNAantibody
(Millipore,MAB3034) to ensure equal loading of DNA. Chemi-
luminescent detection was performed as described above, and
all signals were normalized to non-irradiated control samples.
All experiments were repeated between two and ten times
(as indicated), and representative results are presented. A
Student’s t test was used to determine statistically significant
differences between treatment groups.
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